经皮冠状动脉介入治疗术前单次负荷剂量与常规剂量瑞舒伐他汀对冠心病患者预后的影响

doi:10.3969/j.issn.1004-583X.2018.06.009

临床荟萃

经皮冠状动脉介入治疗术前单次负荷剂量与常规剂量瑞舒伐他汀对冠心病患者预后的影响

周口市中心医院心内科，河南周口 466000

出版日期:2018-06-05 发布日期:2018-06-25
通讯作者: 通信作者：魏振衡， Email: yangxiaoyuhou@126.com

PCI preoperative single load dose and conventional dose risuvastatin on prognosis of patients with coronary heart disease

Department of Cardiology, Zhoukou Central Hospital, Zhoukou 466000, China

Online:2018-06-05 Published:2018-06-25
Contact: Corresponding author: Wei Zhenheng, Email: yangxiaoyuhou@126.com

摘要/Abstract

摘要： 目的探讨经皮冠状动脉介入治疗(PCI)术前单次负荷剂量与常规剂量瑞舒伐他汀对冠心病患者预后的影响。方法选取我院接受PCI介入诊治的患者108例，随机分为常规组和负荷组，每组各54例，分别在术前12小时使用常规剂量和负荷剂量的瑞舒伐他汀，常规剂量为5 mg，负荷剂量为20 mg，术后均使用常规剂量5 mg连续服用。收集所有患者在PCI术前的基线资料，检测术后心肌指标物，并进行随访。观察比较其各项指标的变化情况、主要不良心血管事件（MACE）及瑞舒伐他汀的肝毒性和肌毒性发生情况并进行率的比较。结果心肌指标物心肌肌钙蛋白T(cTnT)、单核细胞趋化蛋白1(MCP1)、C反应蛋白(CRP)、肌酸激酶同工酶(CKMB)在术后24小时、7天的测量水平均较术前有所上升，两组比较差异有统计学意义（P＜0.05）；随访记录术后30天内MACE及瑞舒伐他汀的肝毒性和肌毒性发生情况，两组差异比较有统计学意义（P＜0.05）。结论 PCI术前单次负荷剂量瑞舒伐他汀对冠心病患者预后具有积极意义，可以在术前使用负荷剂量他汀药物来减少术后心脏不良事件的发生。

关键词: 冠状动脉疾病, 血管成形术, 经腔, 经皮, 冠状动脉, 预后

Abstract: Objective To investigate the effect of single loading dose and conventional dose of rosuvastatin on the prognosis of patients with coronary heart disease before and after percutaneous coronary intervention (PCI). Methods Totally 108 patients who underwent PCI intervention in our hospital were randomly divided into conventional group (n=54, rosuvastatin 5 mg at 12 h preoperatively) and loading group (n=54, rosuvastatin 20 mg at 12 h preoperatively). After operation, all patients in two groups took contineously the conventional dose of rosuvastatin 5 mg. Basic clinical indexes, myocardial basic indicators and followup for the whole patients were detected before and after PCI. Meanwhile, changes in each index, major adverse cardiovascular events (MACE), hepatotoxicity and myotoxicity of rosuvastatin were observed and compared. Incidence of MACE, hepatotoxicity and myotoxicity of rosuvastatin were compared respectively. Results The levels of myocardial markers, cardiac troponin T(cTnT), monocyte chemotactic protein1(MCP1), C reactive protein (CRP) and creatine kinase (CKMB) at 24 h and 7 d postoperatively rose as compared with those before PCI, indicating statistically significant differences bewteen conventional group and loading group (P<0.05); Followup of MACE, hepatotoxicity and myotoxicity of rosuvastatin within 30 d and 1 year postoperatively were recorded and revealed statistically significant differences (P<0.05). Conclusion The single loading dose of rosuvastatin before PCI is of positive significance for the prognosis of patients with coronary heart disease. Moreover, application of loading dose of statins before operation can reduce postoperative adverse cardiac events.

Key words: coronary disease, angioplasty, , transluminal, , percutaneous coronary, prognosis

魏振衡，张军堂. 经皮冠状动脉介入治疗术前单次负荷剂量与常规剂量瑞舒伐他汀对冠心病患者预后的影响[J]. 临床荟萃, doi: 10.3969/j.issn.1004-583X.2018.06.009.

Wei Zhenheng, Zhang Juntang. PCI preoperative single load dose and conventional dose risuvastatin on prognosis of patients with coronary heart disease[J]. Clinical Focus, doi: 10.3969/j.issn.1004-583X.2018.06.009.

导出引用管理器 EndNote|Ris|BibTeX

链接本文: https://huicui.hebmu.edu.cn/CN/10.3969/j.issn.1004-583X.2018.06.009

https://huicui.hebmu.edu.cn/CN/Y2018/V33/I6/494

[1]	黄宇玲, 张欣悦, 荣萍萍, 杨文琦, 曹新营, 邢彩耐, 王志军, 刘宁. Non-HDL-C/HDL-C和NHR与冠状动脉病变严重程度的相关性[J]. 临床荟萃, 2024, 39(2): 115-120.
[2]	赵旭辉, 黄小敏, 达德转, 许焱, 崔晓东, 李红玲. 基于生物信息学筛选影响胃癌患者预后的糖酵解相关基因[J]. 临床荟萃, 2024, 39(1): 20-29.
[3]	刘丽丽, 袁宇婷, 赖耿良, 田川, 蓝翔, 叶中绿. 儿童急性淋巴细胞白血病第15天微小残留与预后的关系[J]. 临床荟萃, 2024, 39(1): 47-52.
[4]	崔兰丹, 杨春燕. 脓毒症患者甲状腺激素的变化特点及研究进展[J]. 临床荟萃, 2024, 39(1): 70-74.
[5]	邹子良, 余海, 王迪, 褚泰运, 李驹, 钱宝堂. 冠状动脉慢性完全闭塞病变介入治疗研究现状[J]. 临床荟萃, 2024, 39(1): 80-83.
[6]	魏宇涵, 赵亚楠, 张桂彬, 吴雨晴, 董博华, 扈家源, 杨文琦. 单核细胞/高密度脂蛋白胆固醇比值、红细胞分布宽度、尿酸与冠心病患者冠状动脉病变严重程度的相关性[J]. 临床荟萃, 2023, 38(9): 796-801.
[7]	李华, 陈建军, 未纪涛, 张旗. 血清胱抑素C水平与非阻塞性冠状动脉疾病的关系[J]. 临床荟萃, 2023, 38(9): 802-805.
[8]	马国菲, 匡时权. 甲状旁腺激素联合颈动脉内膜中层厚度对冠状动脉钙化的预测作用[J]. 临床荟萃, 2023, 38(8): 694-701.
[9]	王涛, 高玉伟, 王兴华, 胡秀红, 崔红蕊, 徐保振, 杨洪娟. 抗磷脂酶A2受体抗体与特发性膜性肾病的相关性[J]. 临床荟萃, 2023, 38(7): 606-612.
[10]	刘铎, 李燕玲, 郭朝霞, 李建锋, 张惠娟, 谢萍. 左冠状动脉异常起源于主肺动脉综合征1例并文献复习[J]. 临床荟萃, 2023, 38(7): 618-622.
[11]	苏晨蓓, 王富军. 糖尿病下肢动脉疾病介入治疗疗效的研究进展[J]. 临床荟萃, 2023, 38(6): 569-572.
[12]	高秦宇, 包蓓艳, 金燕, 赵宇. IgA肾病合并抑郁状态患者的临床特征和预后影响因素分析[J]. 临床荟萃, 2023, 38(6): 510-515.
[13]	孙星星, 林海. 儿童重症肺炎的免疫功能变化及预后危险因素[J]. 临床荟萃, 2023, 38(6): 521-525.
[14]	贺翔渝, 潘燕, 张小林. 血清脂蛋白相关磷脂酶A2水平与急性缺血性脑卒中病情及预后的关系[J]. 临床荟萃, 2023, 38(4): 315-318.
[15]	杨金强, 张仁敏. 降钙素原与血小板比值评估发热伴血小板减少综合征预后的价值[J]. 临床荟萃, 2023, 38(4): 346-351.

经皮冠状动脉介入治疗术前单次负荷剂量与常规剂量瑞舒伐他汀对冠心病患者预后的影响

PCI preoperative single load dose and conventional dose risuvastatin on prognosis of patients with coronary heart disease

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价